Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,429 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Front Page News: New Front-of-Package Food Labelling Requirements

    On July 20, 2022, amendments to the Food and Drug Regulations came into effect, introducing a new nutrition symbol for prepackaged foods. Part of Health Canada's Healthy...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Blake, Cassels & Graydon LLP
    Blake, Cassels & Graydon LLP
  • Article

    FTC Crackdown On Health Claims For CBD Products And The Canadian Side Of The Story

    The U.S. Federal Trade Commission (FTC) announced last week it had sent warning letters to three companies advertising cannabidiol products with unproven claims
    CanadaFood, Drugs, Healthcare, Life Sciences
    Bennett Jones LLP
Bennett Jones LLP
  • Article

    Governments of British Columbia and Québec Announce Changes to Generic Drug Pricing

    In our June 2010 Legal Update we reported that the Ontario Ministry of Health and Long-Term Care had announced amendments to its drug reimbursement and drug interchangeability regulations that impacted, among other things, prices for generic drugs in the province.
    CanadaFood, Drugs, Healthcare, Life Sciences
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Group Of Popular Arthritis Drugs May Pose Risk Of Heart Problems, Blood Clots, Cancer And Death, Says Health Canada

    An entire class of popular arthritis medications – JAK Inhibitors – may expose users to risks of heart attack, stroke, blood clots, cancer, and death, according to a new Summary Safety Review issued by Health Canada.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Siskinds LLP
    Siskinds LLP
  • Article

    Health Canada's Self-Care Framework Proposes Overhaul Of Natural Health Product Regulation

    Health Canada is proposing a complete overhaul of the regulatory framework for "self-care products," a category which encompasses natural health products, non-prescription/"OTCs" and cosmetic products.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Aims To Reduce Red Tape By Increasing International Collaboration, Alignment And Reliance

    In July 2025, the Government of Canada launched a "Red Tape Review" across all federal departments to modernize regulatory frameworks and support economic growth.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Announces New Front-of-package Label Regulations

    Today the Minister of Health announced new front-of-package nutrition labelling regulations for packaged food that are high in saturated fat, sugars and/or sodium.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Pushes Forward With Nutrition Labelling Changes

    On June 13, 2015, the Government of Canada published proposed amendments to the Food and Drug Regulations that, if adopted, would significantly change key elements of the nutrition labelling of food products.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Blake, Cassels & Graydon LLP
    Blake, Cassels & Graydon LLP
  • Article

    Health Canada Releases Medical Devices Action Plan

    On December 20, 2018, Health Canada published an Action Plan on Medical Devices: Continuously Improving Safety, Effectiveness and Quality.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Seeks Input On New Draft Guidance For Co-packaged Drug Products

    On March 18, 2025, Health Canada released a Notice that it is seeking feedback on a draft guidance on co-packaged drug products.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Information Shouldn't Be Shared Via Fax Or Unsecured Email, Privacy Commissioners Urge

    The privacy commissioners said fax machines and unencrypted emails – along with snooping cases and ransomware attacks – have led to numerous privacy breaches in the health care sector.
    CanadaFood, Drugs, Healthcare, Life Sciences
    MLT Aikins LLP
    MLT Aikins LLP
  • Article

    Health Law Group Spotlight: New Partner Daniel Girlando

    The Health Law Group is pleased to welcome its newest partner — Daniel Girlando. Daniel is a graduate of McGill University and has a long history with our firm. He articled with BLG in 2010-2011
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Impact Of The All Families Are Equal Act, 2016 For Surrogate Births

    The recent All Families Are Equal Act, 2016 (the "Act") amends various existing pieces of legislation in connection with the goal of establishing new rules related to parentage (see the amendments here).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    IPC Releases Guidance On Communicating PHI By Email

    The Fact Sheet sets out a number of requirements that the IPC will expect health information custodians to meet if they decide to use email to communicate personal health information.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    La Cour Supérieure Du Québec Statue Que Le Régime Du CEPMB Est Constitutionnel, Mais Elle Invalide Les Dispositions Relatives À La Déclaration Des Rabais Consentis À Des Tiers

    Cette mise à jour est destinée aux fabricants de médicaments, notamment aux titulaires de brevets pharmaceutiques.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Fasken
    Fasken
  • Article

    Magnifying MedsCheck Misuse: Pharmacists Take Note

    Recent news stories have highlighted concerns that pharmacists are misusing the MedsCheck program which reimburses pharmacies for conducting medication reviews.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Rosen Sunshine LLP
    Rosen Sunshine LLP
  • Article

    Medical Device Updates: MDEL Modernization, Class III & IV Licence Applications, And MDD Performance Reports

    Health Canada has announced significant regulatory changes for medical device establishment licensing, set to take effect in December 2026. These Phase II amendments aim to streamline requirements...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Medical Devices Updates: Mandatory Use Of The Regulatory Enrolment Process For Medical Devices And Updated Guidance Documents Related To The Regulatory Enrolment Process

    Health Canada released a notice to industry on April 24, 2026, outlining that manufacturers must use the Regulatory Enrolment Process (REP) and Common Electronic Submission Gateway (CESG) for medical device transactions as of April 1, 2026. As we previously reported, manufacturers of medical devices could voluntarily use the REP and CESG for medical device regulatory transactions as of July 2024.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    More Transparency In Health Care: Ontario's Proposed "Sunshine" Legislation

    The Ontario Government introduced a bill on September 27 to enact legislation aimed at strengthening transparency in Ontario's health care sector.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Torys
    Torys
  • Article

    National Pharmacare Update

    On September 23, 2020, the government identified national pharmacare, a national program to fund prescription drugs in Canada, as a continued priority in the Speech from the Throne (the Speech) to open the Second Session ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 741–760 of 3429 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics